about
Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory BiomarkersSoluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15-34 years of age: a prospective cohort study.Twist 1 regulates the expression of PPARγ during hormone-induced 3T3-L1 preadipocyte differentiation: a possible role in obesity and associated diseases.The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patientsDeletion of TNF-like weak inducer of apoptosis (TWEAK) protects mice from adipose and systemic impacts of severe obesity.HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels.The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study.Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation.The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.Regulation of Tissue Responses: The TWEAK/Fn14 Pathway and Other TNF/TNFR Superfamily Members That Activate Non-Canonical NFκB Signaling.Overexpressing STAMP2 attenuates adipose tissue angiogenesis and insulin resistance in diabetic ApoE-/- /LDLR-/- mouse via a PPARγ/CD36 pathway.CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
P2860
Q33616994-268F2DFC-9357-4EE1-A4FF-167827C24A55Q33730507-66156D3C-A753-4034-BDFF-B796FD538C34Q34116406-C0C8F37F-8449-429A-9604-76C312CA62C1Q34309016-085BD7EA-4759-40F9-A38F-55CA48F679E6Q34816377-22A65458-474C-4BB3-BE0E-EFE63D2E87F2Q35866999-BC6F9B7A-B3DE-4ED6-8EEA-3BD285BAC953Q37077884-2DD19DF6-615B-43A4-8706-ADB29DC71982Q38614592-2C340F6C-7748-4207-AC99-075B17FC00B0Q38656281-9B6E7A0B-54F1-48EE-8017-02384E91276CQ38774984-C625CAAC-EF00-44A0-91C7-0C5E67200D59Q40470226-956CB0E0-EA3D-4FF8-B00A-AD844441E0D4Q43169774-18EED135-FAA0-4210-9F70-C683F74BB85FQ47096391-2710D8D3-A7AA-4BFA-8EB1-ED7E2529D0DBQ47972233-E0D7620F-45A9-433A-BC96-C0FED1E1C62B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
TWEAK: A New Player in Obesity and Diabetes.
@en
type
label
TWEAK: A New Player in Obesity and Diabetes.
@en
prefLabel
TWEAK: A New Player in Obesity and Diabetes.
@en
P2860
P356
P1476
TWEAK: A New Player in Obesity and Diabetes
@en
P2093
Matilde R Chacón
P2860
P356
10.3389/FIMMU.2013.00488
P577
2013-12-30T00:00:00Z